# Amneal Pharmaceuticals, Inc.: Form 8-K, filed Apr 22, 2026

- Company: [Amneal Pharmaceuticals, Inc.](/companies/amrx.md) (CIK 1723128)
- Form: 8-K
- Filed: 2026-04-22
- Accepted by EDGAR: Apr 22, 2026, 06:22 ET
- Period: 2026-04-22
- Accession: 0001193125-26-168231
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1723128/000119312526168231/d126526d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1723128/000119312526168231/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.02: Results of operations
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1723128/000119312526168231/d126526d8k.htm

Filed Apr 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-168231. Last ingested by Listed: Nov 10, 2026, 02:45 ET. No prices; not investment advice.
